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Abstract
The abundantly expressed calcium/calmodulin-dependent protein kinase II (CAMK2), alpha
(CAMK2A), and beta (CAMK2B) isoforms are essential for learning and memory formation.
Recently, a de novo candidate mutation (p.Arg292Pro) in the gamma isoform of CAMK2
(CAMK2G)was identified in a patientwith severe intellectual disability (ID), but themechanism(s)
by which this mutation causes ID is unknown. Here, we identified a second, unrelated individ-
ual, with a de novo CAMK2G p.Arg292Pro mutation, and used in vivo and in vitro assays to assess
the impact of this mutation on CAMK2G and neuronal function. We found that knockdown of
CAMK2G results in inappropriate precocious neuronal maturation. We further found that the
CAMK2Gp.Arg292Promutation acts as a highly pathogenic gain-of-functionmutation, leading to
increased phosphotransferase activity and impaired neuronal maturation as well as impaired tar-
geting of the nuclear CAMK2G isoform. Silencing the catalytic site of the CAMK2G p.Arg292Pro
protein reversed the pathogenic effect of the p.Arg292Pro mutation on neuronal maturation,
without rescuing its nuclear targeting. Taken together, our results reveal an indispensable func-
tion of CAMK2G in neurodevelopment and indicate that the CAMK2G p.Arg292Pro protein acts
as a pathogenic gain-of-function mutation, through constitutive activity toward cytosolic targets,
rather than impaired targeting to the nucleus.
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1 INTRODUCTION
Intellectual disability (ID), characterized by an IQ score of <70 and
moderate to severe limitations in adaptive functioning, often has a
genetic cause. Next generation sequencing (NGS) offers a powerful
diagnosticmodality for undiagnosed IDpatients. Currently, despite the
recent identification of more than 700 genes associated with ID, in
approximately half of ID cases, the genetic pathogenicity cannot be
established with certainty, since the mutation has not been identified
before (Vissers, Gilissen, & Veltman, 2016).
Calcium/calmodulin-dependent protein kinase type II (CAMK2) is a
Ser/Thr protein kinase family consisting of four isozymes (CAMK2A,
CAMK2B, CAMK2G, and CAMK2D). CAMK2A and CAMK2B have a
highly abundant and neuron-selective expression. Targeted deletion
of CAMK2A or CAMK2B in mice has revealed their indispensable
requirement for normal cognition (Borgesius et al., 2011; Elgersma
et al., 2002; Giese, Fedorov, Filipkowski, & Silva, 1998; Hell, 2014;
Lisman, Schulman, & Cline, 2002; Lisman, Yasuda, & Raghavachari,
2012; Silva, Paylor, Wehner, & Tonegawa, 1992a; Silva, Stevens, Tone-
gawa, & Wang, 1992b; van Woerden et al., 2009). Moreover, human
CAMK2A and CAMK2B mutations have recently been established as
a cause of ID (Küry et al., 2017). In contrast to CAMK2A andCAMK2B,
much less is known about the other CAMK2 isoforms, CAMK2G and
CAMK2D. However, recently a de novomutation in the CAMK2G gene
(c.875G > C p.Arg292Pro, henceforth denoted as CAMK2GArg292Pro)
was identified in a patient with severe ID (de Ligt et al., 2012). In addi-
tion, here, we describe a second, unrelated individual with ID carrying
the c.875G>Cp.Arg292Promutation, strongly suggesting a causative
role for CAMK2G in ID.
Even though the expression of CAMK2G in the adult brain is
relatively low compared to CAMK2A and CAMK2B (Tobimatsu &
Fujisawa, 1989), CAMK2G is highly abundant in the developing ner-
vous system in rats (Bayer, Löhler, Schulman, & Harbers, 1999) and
in humans, where it is the dominant isoform in the first trimester
in the hippocampus (Figure 1A). Other than a few studies, reporting
associations of common variation in CAMK2G with reduced mem-
ory performance (de Quervain & Papassotiropoulos, 2006), depres-
sion (Li et al., 2013) and chronic inflammatory pain (Pan et al., 2014),
and a recent study proposing that CAMK2G functions as a cal-
cium/calmodulin (Ca2+/CaM) shuttle (Ma et al., 2014), themechanistic
function of CAMK2G during neurodevelopment has remained largely
unknown.
Here, we describe the clinical features of both individuals carry-
ing theCAMK2Gp.Arg292Promutation, the contribution of CAMK2G
to neuronal migration in vivo and neuronal maturation in vitro and
how the CAMK2GArg292Pro mutation affects CAMK2G function. We
found that reduced expression of CAMK2G leads to inappropri-
ate precocious neuronal maturation. Moreover, we demonstrate that
the p.Arg292Pro mutation is a pathogenic gain-of-function mutation,
which renders the CAMK2G protein constitutively active, and causes
a severe impairment of neuronal migration and maturation. Although
the mutation also interferes with nuclear import, we found that the
pathogenic effect we describe is not related to Ca2+/CaM shuttling.
Taken together, our findings establish CAMK2G as a critical regulator
of neurodevelopment and propose a novel mechanism bywhich the ID
mutation, CAMK2GArg292Pro exerts its pathogenic effect.
2 MATERIAL AND METHODS
2.1 Identification of the CAMK2G p.Arg292Pro
patients
Patient 1 was part of a whole-exome sequencing study performed on
patients with severe intellectual disability in Nijmegen, the Nether-
lands (de Ligt et al., 2012).Written consent for use of the patients’ pho-
tos were obtained from the parents. Patient 2 was identified by clin-
ical whole-exome sequencing done as part of a diagnostic evaluation
through the GreenwoodGenetic Center in South Carolina.
2.2 Constructs
The cDNA sequence from human CAMK2GWT (NM_172171.2, variant
without NLS) was obtained from a human brain cDNA library by PCR
(Phusion high fidelity, Thermo Fisher) using the following primers:
Fw 5′ ACATCTGGCGCGCCACCATGGCCACCACCGCCACCTG 3′
and Rev 5′ AAGTCCTTAATTAATTATCACTGCAGCGGTGCGGCAG
3′ and cloned into our dual promoter expression vector (Suppl. Fig.
S1). The cDNA sequence from rat CAMK2AWT and CAMK2BWT were
kindly provided by Tobias Meyer and was cloned into our expres-
sion vector. The NLS version of CAMK2GWT was generated using
the following primers: Fw 5′ CGAGTTCCAGCGTGCACCTAATGC
CACAGAGCAACAACAAAAACAGTCTCG 3′ and Rev 5′ CATTAGGT
GCACGCTGGAACTCGACTTCCTTTTCTTGACACCGCCATCCGAC
3′. The p.Thr287Ala point mutation cDNA was synthesized by
and ordered from GeneCust. The different point mutations were
introduced with site-directed mutagenesis (Invitrogen) using
the following primers: CAMK2G–c.875G > C (p.Arg292Pro), Fw
5′ CTGTGGAGTGTTTGCCCAAGTTCAATGCCCG 3′ and Rev
5′ CGGGCATTGAACTTGGGCAAACACTCCACAG 3′; CAMK2G–
c.128A > G (p.Lys43Arg), Fw 5′ ACGCAGGAGTACGCAGCAAGAAT-
CATCAATACCAAGAAG 3′ and Rev 5′ GTATTGATGATTCTTGCTGCG-
TACTCCTGCGT 3′; CAMK2G–c.859-860AC > GA (p.Thr287Asp),
Fw 5′ GCATCGTCAGGAGGATGTGGAGTGTTTG 3′ and Rev 5′
CAAACACTCCACATCCTCCTGACGATGC 3′; CAMK2G–c.916-
919ACGA > GTGG (p.Thr306Val/Thr307Ala), Fw 5′ CTGAAGGGT-
GCCATCCTCGTGGCCATGCTTGTCTCCAGGA 3′ and Rev 5′ TCCTG-
GAGACAAGCATGGCCACGAGGATGGCACCCTTCAG 3′; CAMK2G–
c.907-909GCC > AGA (p.Ala303Arg), Fw 5′ GAAAACTGAAGGGTA-
GAATCCTCACGACCAT 3′ and Rev 5′ ATGGTCGTGAGGATTC-
TACCCTTCAGTTTTC 3′. CAMK2G–c.1000T > G (p.Ser334Ala),
Fw 5′ GGTGTCAAGAAAAGGAAGGCGAGTTCCAGCGTGCACCT
3′ and Rev 5′ AGGTGCACGCTGGAACTCGCCTTCCTTTTCTTGA
CACC 3′. CAMK2A–c.871-873 AAG > CCT (p.Lys291Pro), Fw 5′
GGAGACCGTGGACTGCCTGCCTAAGTTCAATGCCAGGAGGA 3′
and Rev 5′ TCCTCCTGGCATTGAACTTAGGCAGGCAGTCCACG-
GTCTCC 3′; CAMK2B–c.874-876AAG > CCT (p.Lys292Pro), Fw 5′
GGAGACTGTGGAATGTCTGCCTAAGTTCAATGCAAGGAGGA 3′ and
Rev 5′ TCCTCCTTGCATTGAACTTAGGCAGACATTCCACAGTCTCC
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F IGURE 1 CAMK2G knockdown in primary hippocampal neurons results in increased arborization. (A) Expression levels of human CAMK2A,
CAMK2B, CAMK2D, and CAMK2G in the hippocampus during gestation, showing that CAMK2G is the dominant isoform in the first trimester,
and contributes substantially in the second and the third trimester. Data was extracted from the BrainSpan database
(https://www.brainspan.org/). (B) Representative confocal images of hippocampal neurons co-transfected onDIV7with combinations of control
shRNA, with control vector or CAMK2GWT and an RFP plasmid or shRNA against Camk2gwith control vector or CAMK2GWT and an RFP plasmid.
Transfected neurons are identified by the RFP plasmid (red). See also Supplement 1 related to Figure 1. (C) Sholl analysis of neurite complexity.
(D) Summary bar graphs of total neurite length and arborizationmeasured for each condition and normalized to the control shRNA (total neurite
length: one-way ANOVA, F[3,82]= 8.42, P= 6.05E-05; control vector+control shRNA vs. control vector+Camk2g-shRNA, P= 0.0004;
CAMK2GWT+control shRNA, P= 0.99; CAMK2GWT+Camk2g-shRNA, P= 0.99; control vector+Camk2g-shRNA vs. CAMK2GWT+control shRNA,
P= 0.005; CAMK2GWT+Camk2g-shRNA, P= 0.0002; CAMK2GWT+control shRNA vs. CAMK2GWT+Camk2g-shRNA, P= 0.99; arborization:
one-way ANOVA, F[3,82]= 10.08, P= 1.00E-05; control vector+control shRNA vs. control vector+Camk2g-shRNA, P= 0.0001;
CAMK2GWT+control shRNA, P= 0.99; CAMK2GWT+Camk2g-shRNA, P= 0.99; control vector+Camk2g-shRNA vs. CAMK2GWT+control shRNA,
P= 0.0003; CAMK2GWT+Camk2g-shRNA, P= 0.0005; CAMK2GWT+control shRNA vs. CAMK2GWT+Camk2g-shRNA, P= 0.99)
3′. The dual promoter expression vector was generated from the
pCMV–tdTomato vector (Clonetech), where the CMV promoter was
replaced with a CAGG promoter followed by a multiple cloning site
(MCS) and transcription terminator sequence. To assure expression
of the tdTOMATO independent from the gene of interest, a PGK
promoter was inserted in front of the tdTomato sequence. For all the in
vivo and in vitro experiments, the vector without a gene inserted in the
MCS was taken along as control (control vector). shRNA constructs
were obtained from theMISSIONshRNA library formouse genomesof
Sigma Life Sciences and The RNAi Consortium (TRC). For knockdown
of CAMK2G, we used three different shRNA plasmids, each targeting
a different sequence: (1) GCCCGAGATCATCAGAAACTA, (2) CCT-
GAGGTCTTGAGGAAAGAT, and (3) CTACGCAGGAATATGCTGCAA.
The control shRNA plasmid is theMISSION non-target shRNA control
vector: CAACAAGATGAAGAGCACCAA.
2.3 Mice
For the neuronal cultures, FvB/NHsD females were crossed with
FvB/NHsD males (both ordered at 8–10 weeks old from Envigo). For
the in utero electroporation, female FvB/NHsD (Envigo) were crossed
with male C57Bl6/J (ordered at 8–10 weeks old from Charles River).
All mice were kept group-housed in IVC cages (Sealsafe 1145T, Tecni-
plast) with beddingmaterial (Lignocel BK8/15 fromRettenmayer) on a
12/12 h light/dark cycle in 21◦C (±1◦C), humidity at 40–70% and with
food pellets (801727CRM(P) from Special Dietary Service) and water
available ad libitum. All animal experimentswere approved by the Local
Animal Experimentation Ethical Committee, in accordance with Insti-
tutional Animal Care and Use Committee guidelines.
2.4 HEK-293T cell transfections
To test the expression vector with the CAMK2 constructs, to measure
the phosphorylation levels of CAMK2, and for immunoprecipitation
(IP) experiments, we chose HEK-293T cells, a cell line that is easy
to transfect and culture. These cells were mycoplasma-free but not
authenticated. HEK-293T cells were cultured in DMEM/10% Fetal
Calf Serum (FCS)/1% penicillin/streptomycin in 6-well plates (or 10 cm
dishes for IP experiments) and transfected when 50% confluent with
the following DNA constructs: control vector, CAMK2GWT, CAMK2G-
NLSWT, CAMK2GArg292Pro, CAMK2G-NLSArg292Pro, CAMK2GAla303Arg,
CAMK2AWT, CAMK2ALys291Pro , CAMK2BWT, and CAMK2BLys292Pro (3
ug per 6-well and 18 ug per 10 cm dish). Transfection of the plasmids
was done using polyethylenimine (PEI) according to the manufac-
turer instructions (Sigma). Six to twelve hours after transfection, the
medium was changed to reduce toxicity. Transfected cells were then
used for western blot and Immunoprecipitation experiments.
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2.5 Western blot
Two to three days after transfection, HEK cells were harvested
and homogenized in lysis buffer (10 mM Tris-HCl 6.8, 2.5% SDS,
2 mM EDTA), containing protease inhibitor cocktail (#P8340, Sigma),
phosphatase inhibitor cocktail 2 (#P5726, Sigma) and phosphatase
inhibitor cocktail 3 (#P0044, Sigma). Protein concentration in the
samples was determined using the BCA protein assay kit (Pierce)
and then lysate concentrations were adjusted to 1 mg/ml. Western
blots were probed with primary antibodies against CAMK2G (C-18;
raised against the 478–495 C-terminal peptide, 1:1000, sc-1541,
Santa Cruz; validated in this study by overexpression experiments),
CAMK2A (6G9, 1:40.000, Abcam; validated in Elgersma et al. (2002)),
CAMK2B (CB-𝛽1, 1:10.000, Invitrogen; validated in van Woerden
et al. (2009)), Actin (MAB1501R, 1:20.000, Chemicon; validated
in Antibodypedia (https://Antibodypedia.com), Ph-Thr286/Thr287
(auto-phosphorylated CAMK2 antibody; #06-881; 1:1000; Upstate
Cell Signaling Solutions; validated in Elgersma et al. (2002)) and RFP
(#600401379, 1:2000, Rockland, validated in this study by overex-
pression experiments), and secondary antibodies (goat anti-mouse
(#926-32210), goat anti-rabbit (#926-68021), and donkey anti-goat
(#926-68074), all 1:15.000, LI-COR). Blots were quantified using
LI-COROdyssey Scanner andOdyssey 3.0 software.
2.6 Immunoprecipitation
Two to three days after HEK transfection in 10 cm dishes, cells were
harvested in PBS and cell pellets were taken up in 500 ul of IP
lysis buffer (20 mM Tris pH 8.0, 150 mM NaCl, 1% NP40) supple-
mentedwith protease inhibitor cocktail (#P8340, Sigma), phosphatase
inhibitor cocktail 2 (#P5726, Sigma), and phosphatase inhibitor cock-
tail 3 (#P0044, Sigma). Protein concentration in the sampleswas deter-
mined using the BCA protein assay kit (Pierce) and 600 ug of total pro-
tein adjusted to a volume of 800 ul was used for immunoprecipitation.
20 ul of the total volume was saved as “input.” Cell lysates were incu-
bated with 50 ul of prewashed 50 % slurry Protein A Sepharose CL-
4B beads (#17-0780-01, GE Healthcare) at 4◦C for >1 h. Beads were
then isolated and discarded by spinning down samples at 1000 rpm
for 1′. Lysates were placed in a new tube with 3 ul of mouse calmod-
ulin antibody (C3545, Sigma) and allowed tomix overnight at 4◦C. The
next morning, lysates were incubated with 50 ul of prewashed 50%
slurry Protein G Sepharose beads (#17-0618-01, GE Healthcare) at
4◦C for > 1 h. Beads were then washed 3× with cold lysis buffer and
after final wash proteins were eluted adding 20 ul of 2× Laemmli sam-
ple buffer and boiling for 5′ at 95◦Cbefore processing bywestern blot.
2.7 Primary hippocampal cultures
Primary hippocampal and cortical neuronal cultures were prepared
from FvB/NHsD wild-type mice according to the procedure described
in Goslin and Banker (1991). Briefly, hippocampi were isolated from
brains of E16.5 embryos and collected altogether in 10 ml of neu-
robasal medium (NB, Gibco) on ice. After two washings with NB,
the samples were incubated in pre-warmed trypsin/EDTA solution
(Invitrogen) at 37◦C for 20 min. After 2× washing in pre-warmed NB,
the cells were resuspended in 1.5 ml NB medium supplemented with
2% B27, 1% penicillin/streptomycin, and 1% glutamax (Invitrogen),
and dissociated using a 5 ml pipette. Following dissociation, neurons
were plated in a small drop on poly-d-lysine (25 mg/ml, Sigma) coated
15 mm glass coverslips at a density of 1×106 cells per coverslip in 12
well plates containing 1ml of supplementedNB for each coverslip. The
plates were stored at 37◦/5%CO2 until the day of the transfection.
2.8 Neuronal transfection and
immunocytochemistry
Neurons were transfected after 7 days in vitro (DIV) with the following
DNA constructs: control vector (1.8 ug per coverslip), CAMK2GWT,
CAMK2GArg292Pro, CAMK2GLys43Arg, CAMK2GLys43Arg/Arg292Pro ,
CAMK2GThr287Ala, CAMK2GThr287D/Thr306Val/Thr307Ala , CAMK2GAla303Arg,
CAMK2G-NLSWT, CAMK2G-NLSArg292Pro, CAMK2G-NLSSer334Ala,
CAMK2G-NLSSer334Ala/Arg292Pro, CAMK2G-NLSLys43Arg/Arg292Pro,
CAMK2AWT, CAMK2ALys291Pro, CAMK2BWT, and CAMK2BLys292Pro
(all 2.5 ug per coverslip) or for knockdown experiments with a pool of
the CAMK2G shRNAs with an RFP plasmid (Addgene) or the control
shRNA with an RFP plasmid (all in total 4 ug per coverslip). Lipofec-
tamine 2000was used to transfect neurons, according to themanufac-
turer instructions (Invitrogen). For the neuronal morphology analysis,
neurons were fixed 5 days post-transfection with methanol and 4%
paraformaldehyde (PFA)/4% sucrose, when stained for CAMK2G and
4% paraformaldehyde/4% sucrose, when stained for CAMK2A or
CAMK2B and incubated overnight at 4◦C with primary antibodies in
GDB buffer (0.2% BSA, 0.8 M NaCl, 0.5% Triton X-100, 30 mM phos-
phate buffer (PB), pH7.4). Tomeasure level of knockdown of CAMK2G
and protein localization, neurons were fixed 5 days post-transfection
with methanol and 4% paraformaldehyde/4% sucrose and stained for
CAMK2G, but for morphological analysis neurons were fixed with 4%
paraformaldehyde/4% sucrose and processed without staining for
CAMK2G. The following primary antibodies were used: MAP2 (1:500,
#188004, Synaptic System, validation canbe foundon themanufactur-
erswebsite: https://www.sysy.com/products/map2/ref.php), CAMK2G
(C-18, 1:100, Santa Cruz), CAMK2A (6G9, 1:200, Abcam), CAMK2B
(CB-𝛽1, 1:100, Invitrogen). For secondary antibodies, anti-mouse-
Alexa488 (#715-545-150), anti-goat-Alexa488 (#705-545-003), and
anti-guinea-pig-Alexa647 (#706-605-148) conjugated antibodies (all
1:200, Jackson ImmunoResearch) were used. For the localization
experiments, neurons were also stained with 4′,6-diamidino-2-
phenylindole solution (DAPI, 1:10000, Invitrogen) for 15′ before being
mounted on glass. Slides weremounted usingMowiol-DABCO (Sigma)
mounting medium. Confocal images were acquired using a LSM700
confocal microscope (Zeiss).
For the analysis of the neuronal transfections, at least 10 confo-
cal images (20× objective, 0.5 zoom, 1024 × 1024 pixels) of differ-
ent transfected neurons (identified by the red staining) were taken
fromeach coverslip for each experimentwith at least two independent
replications. For the analysis of the neuronal morphology, the Neu-
ronJ plugin for ImageJ software was used to trace the dendrites with
their branches. Total neurite length and arborization were measured
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and analyzed. All values were normalized against the mean value for
each parameter of the control (control vector). Sholl analysis for the
in vitro knockdown experiment was performed by counting the num-
ber of neurite intersections between the traced neurons and a series
of concentric circumferences at an interval of 10 um from each other
with the center on the soma. For the analysis of the protein levels upon
shRNA transfection, the “Measure RGB” plugin from ImageJ software
wasused tomeasure the intensity of the fluorescent signal of the trans-
fected cell, which was normalized against non-transfected cells on the
same coverslip and then normalized against the mean value of control
shRNA transfected cells. For the analysis of the protein localization
experiments, the DAPI staining was used to identify the nucleus and
define a region of interest (ROI). To measure the intensity of the flu-
orescent signal relative to the protein of interest of the ROI nucleus
and the ROI cytoplasm of each transfected cell, we used the “Mea-
sure” plugin of Fiji software. The intensity signal (Integrated density)
was corrected for the area of the ROI and the background signal by
using the following formula: IntDen–(area of the ROI × mean fluores-
cence of background reading). The ratio of the nucleus/cytoplasm cor-
rected intensity value for each constructwas averaged and normalized
against the averaged ratio of theWTof the same neuronal batch. Anal-
ysis was done by an experimenter blinded for the transfection condi-
tions.
2.9 In utero electroporation
The procedurewas performed in pregnant FvB/NHsDmice at E14.5 of
gestation to target mainly the progenitor cells giving rise to pyramidal
cells of the layer 2/3 (Saito, 2006; Taniguchi, Young-Pearse, Sawa, &
Kamiya, 2012). The DNA construct (1.5–3 ug/ul) was diluted in fast
green (0.05%) and injected in the lateral ventricle of the embryos
while still in uterus, using a glass pipette controlled by a Picospritzer
III device. To ensure the proper electroporation of the injected
DNA constructs (1–2 ul) into the progenitor cells, five electrical
square pulses of 45 V with a duration of 50 ms per pulse and 150 ms
inter-pulse interval were delivered using tweezer-type electrodes
connected to a pulse generator (ECM 830, BTX Harvard Apparatus).
The electrodes were placed in such a way that the positive pole was
targeting the developing somatosensory cortex. The following plas-
mids were injected: control vector, CAMK2GWT, CAMK2GArg292Pro,
CAMK2GLys43Arg , CAMK2GLys43Arg/Arg292Pro , CAMK2GThr287Ala,
CAMK2GThr287Asp/Thr306Val/Thr307Ala , CAMK2GAla303Arg, CAMK2G-NLSWT,
CAMK2G-NLSArg292Pro , CAMK2G-NLSLys43Arg/Arg292Pro, CAMK2AWT,
CAMK2ALys291Pro , CAMK2BWT, and CAMK2BLys292Pro or for knockdown
experiments: a pool of the CAMK2G shRNAs with an RFP plasmid
(Addgene) or the control shRNAwith an RFP plasmid. After birth, pups
(M/F) were sacrificed at P18-P22 for histochemical processing.
2.10 Immunohistochemistry
Mice were deeply anesthetized with an overdose of Nembutal
and transcardially perfused with 4% paraformaldehyde. Brains were
extracted and post-fixed in 4% PFA. Brains were then embedded in
gelatin and cryoprotected in 30% sucrose in 0.1 M phosphate buffer,
frozen on dry ice, and sectioned using a freezing microtome (40–50
𝜇m thick). Free-floating coronal sections were washed in 0.1 M PB
and a few selected sections were counterstained with 4′,6-diamidino-
2-phenylindole solution (DAPI, 1:10,000, Invitrogen) before being
mounted with Mowiol on glass. Overview images of the coronal sec-
tions were acquired by tile scan imaging using a LSM700 confocal
microscope (Zeiss) with a 10× objective. Zoom in images of the tar-
geted area were taken using a 20× objective.
For the migration analysis, confocal images (10× objective, 0.5
zoom, 1024 × 1024 pixels) were taken from 2 to 3 non-consecutive
sections from at least three successfully targeted animals per plas-
mid. Images were rotated to correctly position the cortical layers, and
the number of cells in different layers were counted using ImageJ
(Analyze particles option), and the results were exported to a spread-
sheet for further analysis. Cortical areas from the pia to the ventricle
were divided in 10 equal-sized bins and the percentage of tdTOMATO-
positive cells per bin was calculated.
2.11 Statistical analysis
All data was assumed to be normally distributed. Statistical differ-
ence between the conditions for the in vitro overexpression experi-
ments was determined using one-way analysis of variance (ANOVA)
followed by Bonferroni's post-hoc test for multiple comparisons and
for the knockdown experiments using the two-tailed unpaired t-test
(dual comparison). For the western blot analysis, one-tailed and two-
tailed unpaired t-testwas used (dual comparison). For the in vivo exper-
iments on neuronal migration, the analysis was performed on the num-
ber of targeted cells, measured as sum of the first four bins, consid-
ered to correspond to the layers 2/3 of the somatosensory cortex.
Statistical analysis was performed using one-way ANOVA, followed
by Bonferroni's multiple comparison tests. Based on previous experi-
ments performed inour lab,we considered that for theneuronal exper-
iments in vitro at least two replicates, with 10 neurons each were nec-
essary. For thewesternblot analysis,we consideredat least three repli-
cates, and for the IUE experiments, previous experiments in our lab-
oratory showed that at least three targeted pups were necessary to
draw any conclusion about the migration. P-values are indicated in the
figures with “*”: * indicates P < 0.05, ** indicates P < 0.01, *** indicates
P< 0.0001.
3 RESULTS
3.1 CAMK2G p.Arg292Promutation causes severe
intellectual disability
Patient 1 carrying the CAMK2G p.Arg292Pro mutation has already
briefly been described in a whole-exome sequencing study describing
several individuals with severe ID (de Ligt et al., 2012). Here, we identi-
fied a second, unrelated carrier of the heterozygous de novo CAMK2G
p.Arg292Promutation (patient 2). He presented in infancywith gener-
alized hypotonia anddevelopmental delay andhas remained hypotonic
with markedly delayed gross motor and speech/language skills. He is
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currently diagnosed with severe ID and autism at 5 years of age. His
physical exams have been notable for relative macrocephaly, promi-
nent capillary vascular malformations on the forehead and glabella,
minor dysmorphic facial features, and severe hypotonia. A detailed
description of both patients is provided in Suppl. Fig. S2. Both patients
suffer fromsevere IDandseverehypotonia. Theybothhave some facial
dysmorphisms (Suppl. Fig. S2), though not strikingly similar. By com-
parison, although individuals with mutations in CAMK2A or CAMK2B
all suffer from ID and in most cases hypotonia, facial dysmorphisms
are not commonly observed among individuals carrying mutations in
CAMK2A or CAMK2B (Küry et al., 2017).
3.1.1 Knockdown of CAMK2G causes increased neuronal
arborization
Identifying two unrelated patients with a severe neurodevelopmental
disorder carrying the same mutation in CAMK2G, strongly suggests
that CAMK2G plays a role in neurodevelopment and neuronal func-
tioning. However, whereas the indispensable roles of CAMK2A and
CAMK2B for neuronal plasticity and cognitive function are well
established, the neuronal function of CAMK2G remains poorly char-
acterized. Considering the highly abundant expression of CAMK2G in
the first trimester during which the nervous system starts to develop
and the stable expression during the rest of the prenatal period (Fig-
ure 1A), we set out to investigate the role of CAMK2Gduring neuronal
maturation in vitro, using shRNAs to effect knockdownof theCAMK2G
protein. We transfected mouse primary hippocampal neurons with
shRNAs directed against Camk2g or a control plasmid, together with
a red florescent protein (RFP) reporter plasmid to visualize trans-
fected neurons. Despite the CAMK2G antibody cross-reactivity with
CAMK2A and CAMK2B (Suppl. Fig. S3), we nevertheless observed
a 35% reduction of immunofluorescent signal 5 days after trans-
fection, without any change in CAMK2A or CAMK2B levels (Suppl.
Fig. S3) consistent with a robust decrease specifically of CAMK2G.
Transfection of Camk2g shRNA resulted in a substantial alteration
of neuronal morphology, with a clear increase in the complexity of
the neurite tree compared to the control condition, as measured by
Sholl analysis (Figure 1C). Additional quantification of the neurite
length and arborization revealed that neurons with reduced levels of
CAMK2G exhibited a 38% increase in total neurite length and 55%
increase of arborization compared to the control condition (Figure 1B
and D, see figure legend for statistics). Mice express three CAMK2G
isoforms, one of which contains a nuclear localization signal (NLS)
(Suppl. Fig. S4A). This isoform is present in both cytosol and nucleus
and was recently proposed to shuttle Ca2+/CaM into the nucleus (Ma
et al., 2014). In order to assess to what extent the observed effect on
neurite length and arborization was specific for the down-regulation
of CAMK2G and whether there is differential contribution of the
CAMK2G isoforms, we co-transfected either the human CAMK2G
isoform lacking the NLS (CAMK2G), the CAMK2G isoform containing
the NLS (CAMK2G-NLS), CAMK2A or CAMK2B together with the
shRNA against mouse Camk2g. Whereas co-transfection of CAMK2A
or CAMK2B with Camk2g shRNA had no effect on total neurite length
(Suppl. Fig. S4B and C), co-transfection of CAMK2G or CAMK2G-NLS
withCamk2g shRNAboth resulted in a complete rescueof theneuronal
morphology phenotype caused by the down-regulation of CAMK2G
(Figure 1B–D and Suppl. Fig. S4B and C). These results indicate that
CAMK2G is indispensable for regulating neuronal morphology, but
that this function does not require its nuclear import.
3.1.2 The CAMK2GArg292Pro mutation is pathogenic both in
vitro and in vivo
To study the effect of the ID-associated CAMK2G missense variant
on neuronal function, we cloned the human CAMK2G gene with and
without the c.875G>Cmutation in a dual promoter expression vector
(see Section “Material and Methods”). Transfection of HEK-293T cells
with CAMK2GArg292Pro achieved a 10-fold lower CAMK2G protein
signal compared to that achieved by transfection with CAMK2GWT,
despite equal tdTomato levels, indicating that the p.Arg292Pro muta-
tion affects protein stability (Figure 2A and B). Next, we investi-
gated the effect of expression of CAMK2GWT and CAMK2GArg292Pro
in primary hippocampal neurons. Despite the reduced stability of
CAMK2GArg292Pro, levels of CAMK2G were increased in neurons
transfected (tdTomato-positive) with CAMK2GArg292Pro (Figure 2C).
Whereas expression of CAMK2GWT yielded no discernible morpho-
logical changes with respect to total neurite length or arborization,
expression of CAMK2GArg292Pro strongly reduced total neurite length
as well as arborization, which was notably in the opposite direction as
observed followingCamk2g knockdown (Figure 2D). These results sug-
gest that the p.Arg292Promutation functions as a pathogenic gain-of-
function.
To evaluate the effect of CAMK2GArg292Pro expression in vivo, we
used in utero electroporation at E14.5. This assay measures the abil-
ity of targeted neural cells in the subventricular zone to successfully
migrate to layer 2/3 of somatosensory cortex. This assay is very sen-
sitive for changes that perturb normal neural cell function (Saito &
Nakatsuji, 2001; Tabata & Nakajima, 2001; Taniguchi et al., 2012).
Strikingly, cells expressing CAMK2GArg292Pro exhibited a complete
block of migration from the subventricular zone, despite more than
80% of the cells expressing CAMK2GWT having migrated normally to
layer 2/3 of the somatosensory cortex (Figure 2E and F). These results
further confirm the severe dominant effect of the p.Arg292Pro muta-
tion on CAMK2G function.
Taken together these data suggest that although CAMK2GArg292Pro
has reduced protein stability, this mutation does not lead to a loss of
function of CAMK2G, but instead appears to result in a paradoxical
gain-of-function.
3.1.3 CAMK2GArg292Pro has increased phosphotransferase
activity
Considering that a gain-of-function mediates the effects of
CAMK2GArg292Pro and that the p.Arg292Pro mutation is located
within the 𝛼-helical auto-regulatory domain of CAMK2G that main-
tains the kinase in an inactive state in the absence of Ca2+/CaM
(Hudmon & Schulman, 2002; Rellos et al., 2010), we hypothesized that
the mechanism for the gain-of-function elicited by CAMK2GArg292Pro
might involve enhanced phosphotransferase or even constitutive
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F IGURE 2 CAMK2GArg292Pro overexpression is
severely disruptive for neurons in vitro and in vivo.
(A) Representative western blot of CAMK2GWT or
CAMK2GArg292Pro (R292P) transfected HEK-293T
cells. (B) Quantification of the levels of CAMK2G
expression, normalized against tdTOMATO in the
different conditions (CAMK2GWT vs.
CAMK2GArg292Pro: t[10]= 16.62, P= 1.30E-08,
two-tailed unpaired t-test). (C) Representative
confocal images of hippocampal neurons
transfected onDIV7with control vector (lacking
CAMK2G), CAMK2GWT or CAMK2GArg292Pro. See
also Supplement 1 related to Figure 2. Transfected
neurons are identified by the tdTOMATO (red).
(D) Summary bar graphs of total neurite length and
arborizationmeasured for each condition and
normalized to the control vector (total neurite
length: one-way ANOVA F[2,89]= 49.35,
P= 3.79E-15; control vector vs. CAMK2GWT,
P= 0.9; CAMK2GArg292Pro, P= 0.0001;
CAMK2GArg292Pro vs. CAMK2GWT, P= 0.0001;
arborization: one-way ANOVA F[2,89]= 31.8,
P= 3.80E-11; control vector vs. CAMK2GWT,
P= 0.9; CAMK2GArg292Pro, P= 0.0001;
CAMK2GArg292Pro vs. CAMK2GWT, P= 0.0001).
(E) Representative images of P20-P22 pups in utero
electroporated at E14.5 with control vector,
CAMK2GWT or CAMK2GArg292Pro tdTOMATO
positive cells indicate the successfully targeted
neurons. DAPI (blue) counterstaining is used to
identify general cortical structure. (F) Left:
quantification of the neuronal migration pattern
from the Layer 1 (L1) to the intermediate zone (IZ);
Right: analysis of the percentage of targeted cells
that reach the outer layers of the cortexmeasured
as sum of bin 1–4 (one-way ANOVA, F[2,20]= 58.88,
P= 4.16E-09; control vector vs. CAMK2GWT,
P= 0.07; CAMK2GArg292Pro, P= 0.0001;
CAMK2GWT vs. CAMK2GArg292Pro, P= 0.0001).
Arrowheads indicate layer 2/3 of the somatosensory
cortex, whereas the arrow indicates the
subventricular zone (SVZ). Data in (B), (D), and (F)
are presented asmean± SEM. Numbers (X/Y)
depicted in the bar graphs represent the number of
samples (B), the total number of cells (X) and number
of independent cultures (Y) (D) or the number of
pictures (F) analyzed
activity. Therefore, we first assessed the level of Thr287 phosphoryla-
tion in HEK-293T cells as readout for the phosphotransferase activity
by expressing either CAMK2GWT or CAMK2GArg292Pro. To allow for a
direct comparison of their relative phosphorylation, we obtained equal
protein levels by titrating the amount of transfected DNA. We found
a significant increase of Thr287 phosphorylation in cells expressing
CAMK2GArg292Pro compared to CAMK2GWT (Figure 3A and B), sug-
gesting that the p.Arg292Pro mutation enhances phosphotransferase
activity and acts as a gain-of-functionmutation.
To further test whether the p.Arg292Promutation affects neuronal
function by acting as a gain of function mutation, we first analyzed
the effect of two mechanistically well-established loss-of-function
CAMK2 mutations on neuronal migration and morphology. The
CAMK2GAla303Arg mutation prevents binding of Ca2+/CaM, and
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F IGURE 3 Overexpression of a dominant active form of CAMK2G is severely disruptive for neurons in vitro and in vivo. (A) Representative
western blot of CAMK2GWT or CAMK2GArg292Pro (R292P) transfected HEK-293T cells. (B) Quantification of the levels of CAMK2G–Thr287
phosphorylation, normalized against total CAMK2G in the different conditions (t[10]= 2.29, P= 0.05 two-tailed unpaired t-test). (C)
Representative confocal images of hippocampal neurons transfected onDIV7with control vector, CAMK2GLys43Arg (K43R), CAMK2GAla303Arg
(A303R) or CAMK2GThr287Asp/Thr306Val/Thr307Ala (T287D/TT306-7VA). Transfected neurons are identified by the tdTOMATO (red). (D) Summary
bar graphs of total neurite length and arborizationmeasured for each condition and normalized to the control vector (total neurite length:
one-way ANOVA, F[3,86]= 24.75, P= 1.23E-11; control vector vs. CAMK2GAla303Arg, P= 0.03; CAMK2GLys43Arg, P= 0.99;
CAMK2GThr287Asp/Thr306Val/Thr307Ala, P= 0.0001; arborization: one-way ANOVA, F[3,86]= 28.29, P= 8.03E-13; control vector vs.
CAMK2GAla303Arg, P= 0.0003; CAMK2GLys43Arg, P= 0.99; CAMK2GThr287Asp/Thr306Val/Thr307Ala, P= 0.0001). (E) Representative images of
P20-P22 pups in utero electroporated at E14.5 with control vector, CAMK2GLys43Arg, CAMK2GAla303Arg or CAMK2GThr287Asp/Thr306Val-Thr307Ala.
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therefore Ca2+/CaM-dependent activation (Fink et al., 2003; Payne
et al., 1988; Shen & Meyer, 1999). In contrast, the CAMK2GLys43Arg
mutation impairs phosphotransferase activity (Fink et al., 2003;
Shen & Meyer, 1999). Notably, neither CAMK2GAla303Arg nor
CAMK2GLys43Arg altered neurite length when expressed in cul-
tured primary hippocampal neurons. Moreover, although a small
but statistically significant increase of arborization was observed in
CAMK2GAla303Arg expressing neurons, no effect of arborization was
found in neurons expressing CAMK2GLys43Arg (Figure 3C and D).
Finally, in vivo neural cell migration was also unaffected by expression
of CAMK2GAla303Arg or CAMK2GLys43Arg (Figure 3E and F). Taken
together these results show that expression of these phosphotrans-
ferase loss-of-function variants does not phenocopy the severe
effects of the ID-associated CAMK2GArg292Pro, indicating that the
CAMK2GArg292Pro mutation is not a loss-of-functionmutation.
We next tested the effect of the
CAMK2GThr287Asp/Thr306Val/Thr307Ala mutant, which has previ-
ously been shown to significantly enhance autonomous activity
due to the combination of a Threonine 287 substitution by the
phospho-mimetic aspartic amino acid (Mayford, Wang, Kandel, &
O'Dell, 1995; Waldmann, Hanson, & Schulman, 1990) together
with prevention of inhibitory phosphorylation at the Thr306 and
307 sites by substituting conserved but non-phosphorylatable
amino acids (Elgersma et al., 2002; Pi et al., 2010a; Pi, Otmakhov,
Lemelin, De Koninck, & Lisman, 2010b). Interestingly, expression
of this CAMK2GThr287Asp/Thr306Val/Thr307Ala mutant in HEK-293T
cells also achieved severe reduction of CAMK2G protein sig-
nal compared to cells transfected with CAMK2GWT (data not
shown). Consistent with the hypothesis that increased phospho-
transferase activity is a critical mediator of the gain-of-function
mechanism underlying the p.Arg292Pro mutation, expression
of the CAMK2GThr287Asp/Thr306Val/Thr307Ala mutant phenocopied
CAMK2GArg292Pro with similarly severe reductions of total neurite
length (Figure 3C), arborization (Figure 3D), and neuronal migration
(Figure 3E and F). These findings lend additional support to a model
whereby the CAMK2GArg292Pro mutation acts as a gain-of-function
mutation by rendering CAMK2G constitutively active.
3.1.4 CAMK2G-NLSArg292Pro has impaired nuclear
translocationwhile permitting calmodulin binding
Recently, it was shown that CAMK2G functions as a shuttle for
Ca2+/CaM into the nucleus (Ma et al., 2014). Hence, we investigated
if the p.Arg292Pro mutation impacts this shuttling function. Using
the nuclear localization signal-containing isoform of CAMK2G, we
first confirmed the functional impact of CAMK2G-NLSArg292Pro on
F IGURE 4 The CAMK2G-NLSArg292Pro does not disrupt calmodulin
binding. Representative western blot of a calmodulin
immunoprecipitation experiment performed in HEK-293T cells
transfected with either control vector, CAMK2G-NLSWT,
CAMK2G-NLSArg292Pro (R292P), CAMK2GAla303Arg (A303R), or
non-transfected (NT), probedwith an antibody against CAMK2G,
tdTOMATO, and calmodulin (CaM). Note the clear increase in
CAMK2G pull-down (in the presence of CaM antibody, left blot) in the
mutant CAMK2G-NLSArg292Pro lane compared to theWT, despite the
reduced stability of themutant (as observed in the input). As
expected, no detectable CAMK2G is observed in the
CAMK2GAla303Arg mutant lane. The “+” or “—” sign indicates the
presence or absence, respectively of the calmodulin antibody
neuronal maturation and migration, which yielded the similarly severe
neurodevelopmental impairments as CAMK2GArg292Pro (Suppl. Fig.
S5). We then investigated whether CAMK2G-NLSArg292Pro affects
CaM binding by performing a CaM immunoprecipitation. Despite
reduced expression levels, we found thatmoreCAMK2G-NLSArg292Pro
is pulled down using the CaM antibody compared to CAMK2G-NLSWT
(Figure 4), suggesting that CaMbinding is not disrupted, and even pos-
sibly that the affinity of CAMK2G-NLSArg292Pro for CaM is increased.
Next, we assessed whether CAMK2G-NLSArg292Pro has impaired
nuclear translocation. Neurons were transfected with CAMK2G-
NLSArg292Pro and CAMK2G-NLSWT to determine their respective sub-
cellular localization. As expected, we found that CAMK2G-NLSWT
was located in the nucleus as well as the cytoplasm. In contrast,
CAMK2G-NLSArg292Pro was almost exclusively localized to the cyto-
plasm (Figure 5A and B), suggesting that the p.Arg292Pro mutation
disrupts the nuclear localization of CAMK2G-NLS.
tdTOMATO positive cells represent neurons successfully targeted. DAPI (blue) counterstaining is used to identify general cortical structure. (F)
Left: quantification of the neuronal migration pattern from the Layer 1 (L1) to the intermediate zone (IZ); Right: analysis of the percentage of
targeted cells that reach the outer layers of the cortexmeasured as sum of bin 1–4 (one-way ANOVA, F[3,32]= 56.92, P= 6.31E-13; CAMK2GWT
vs. CAMK2GAla303Arg, P= 0.15; CAMK2GLys43Arg, P= 0.99, CAMK2GThr287Asp/Thr306Val/Thr307Ala, P= 0.0001). The dotted line represents the level
reached by the CAMK2G-WT (see Figure 2F for comparison). Arrowheads indicate layer 2/3 of the somatosensory cortex, whereas the arrow
indicates the subventricular zone (SVZ). Data in (B), (D), and (F) are presented asmean± SEM. Numbers (X/Y) depicted in the bar graphs represent
the number of samples (B), the total number of cells (X) and number of independent cultures (Y) (D) or number of pictures (F) analyzed
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F IGURE 5 The CAMK2G-NLSArg292Pro mutation interferes with nuclear translocation of CAMK2G-NLS. (A and C) Representative confocal
images of hippocampal (A) or cortical (C) neurons transfected onDIV7with CAMK2G-NLSWT, CAMK2G-NLSArg292Pro (R292P),
CAMK2G-NLSSer334Ala (S224A), or CAMK2G-NLSArg292Pro/Ser334Ala (R292P/S334A). Transfected neurons are identified by the tdTOMATO (red).
(B andD) Summary bar graphs of CAMK2G expression level measured as a ratio nucleus vs. cytoplasm and normalized to theWT level. (B:
CAMK2GWT vs. CAMK2GArg292Pro, P= 6.81E-19, t(75)= 11.87, two-tailed unpaired t-test; D: one-way ANOVA, F[3,86]= 43.58, P= 3.19E-17;
CAMK2G-NLSWT vs. CAMK2G-NLSArg292Pro, P= 0.0001; CAMK2G-NLSSer334Ala, P= 0.99; CAMK2G-NLSArg292Pro/Ser334Ala, P= 0.0001;
CAMK2GArg292Pro vs. CAMK2G-NLSSer334Ala, P= 0.0001; CAMK2G-NLSArg292Pro/Ser334Ala, P= 0.99; CAMK2G-NLSSer334Ala vs.
CAMK2G-NLSArg292Pro/Ser334Ala, P= 0.0001). Data are presented asmean± SEM. Numbers (X/Y) depicted in the bar graphs represent the total
number of cells (X) and number of independent cultures (Y) analyzed
Nuclear translocation of NLS-containing CAMK2 isoforms requires
a conformational change previously been shown to be dependent
upon dephosphorylation of a Serine immediately adjacent to the
NLS sequence (Ser334 in CAMK2G), resulting in exposure of the
NLS domain (Heist, Srinivasan, & Schulman, 1998; Ma et al., 2014;
Shioda, Sawai, Ishizuka, Shirao, & Fukunaga, 2015). Given that
the p.Arg292Pro mutation enhances the Serine/Threonine kinase
activity of CAMK2G, we sought to investigate whether increased
phosphorylation of the Ser334 residue is a critical mediator of the
abnormal localization of CAMK2G-NLSArg292Pro. Therefore, we
generated the CAMK2G-NLSSer334Ala mutant and the CAMK2G-
NLSArg292Pro/Ser334Ala double mutant constructs to assess their
respective subcellular localization. Whereas CAMK2G-NLSSer334Ala
was localized in both the nucleus and the cytoplasm, CAMK2G-
NLSArg292Pro/Ser334Ala remained exclusively cytoplasmic, indicating
that the mislocalization resulting from the p.Arg292Pro mutation is
not the result of excessive Ser334 phosphorylation (Figure 5C and D).
Taken together, these data show that even though the p.Arg292Pro
mutation does not reduce CaM affinity, it strongly impairs the nuclear
localization of CAMK2G.
3.1.5 Pathogenicity of CAMK2GArg292Pro is not related to
nuclear shuttling of Ca2+/CaM
Our findings indicate that the p.Arg292Pro mutation has two major
effects on CAMK2G: it renders the protein constitutively active and
interfereswith its nuclear targeting. Therefore,wenext aimed to inves-
tigate whether the pathogenicity is caused by the constitutive activity
or by the impairment of nuclear targeting.
To examine whether the constitutive activity results from the
observed increase of Thr287 auto-phosphorylation (Figure 3A and
B), we mutated Threonine 287 to Alanine, a mutation that strongly
reduces autonomous activity (Fong, Taylor, Means, & Soderling, 1989;
Giese et al., 1998; Hanson, Kapiloff, Lou, Rosenfeld, & Schulman,
1989; Ohsako, Nakazawa, Sekihara, Ikai, & Yamauchi, 1991; Waxham,
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F IGURE 6 Auto-phosphorylation at the Thr287 site is dispensable for the phenotype caused by the p.Arg292Promutation. (A) Representative
confocal images of hippocampal neurons transfected onDIV7with control vector, CAMK2GArg292Pro (R292P), CAMK2GThr287Ala (T287A),
CAMK2GThr287Ala/Arg292Pro (T287A/R292P). Transfected neurons are identified by the tdTOMATO (red). (B) Summary bar graphs of total neurite
length and arborizationmeasured for each condition and normalized to the control vector (total neurite length: one-way ANOVA, F[3,70]= 69.33,
P= 6.39E-21; control vector vs. CAMK2GArg292Pro, P= 0.0001; CAMK2GThr287Ala, P= 0.9; CAMK2GThr287Ala/Arg292Pro, P= 0.0001;
CAMK2GArg292Pro vs. CAMK2GThr287Ala, P= 0.0001; CAMK2GThr287Ala/Arg292Pro, P= 0.99; CAMK2GThr287Ala vs. CAMK2GThr287Ala/Arg292Pro,
P= 0.0001; arborization: one-way ANOVA, F[3,71]= 34.88, P= 5.74E-14; control vector vs. CAMK2GArg292Pro, P= 0.0001; CAMK2GThr287Ala,
P= 0.9; CAMK2GThr287Ala/Arg292Pro, P= 0.0001; CAMK2GArg292Pro vs. CAMK2GThr287Ala, P= 0.0001; CAMK2GT287A/R292P, P= 0.99;
CAMK2GThr287Ala vs. CAMK2GThr287Ala/Arg292Pro, P= 0.0001). (C) Representative image of a P20 pup in utero electroporated at E14.5 with
CAMK2GThr287Ala or CAMK2GThr287Ala/Arg292Pro. tdTOMATOpositive cells represent neurons successfully targeted. DAPI (blue) counterstaining
is used to identify general cortical structure. (D) Upper graph: quantification of the neuronal migration pattern from the Layer 1 (L1) to the
intermediate zone (IZ); Lower graph: analysis of the percentage of targeted cells that reach the outer layers of the cortexmeasured as sum of bin
1–4 (one-way ANOVA, F[2,16]= 24.34, P= 1.40E-05; CAMK2GWT vs. CAMK2GThr287Ala, P= 0.99; CAMK2GThr287Ala/Arg292Pro, P= 0.0001;
CAMK2GThr287Ala vs. CAMK2GThr287Ala/Arg292Pro, P= 0.0001). The dotted line represents the level reached by the CAMK2G-WT (see Figure 2F
for comparison). Arrowheads indicate layer 2/3 of the somatosensory cortex, whereas the arrow indicates the subventricular zone (SVZ). Data in
(B) and (D) are presented asmean± SEM. Numbers (X/Y) depicted in the bar graphs represent the total number of cells (X) and number of
independent cultures (Y) (B) or number of pictures (D) analyzed
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Aronowski, Westgate, & Kelly, 1990). Expression of CAMK2GThr287Ala
resulted in no discernible effects on morphology or neural cell migra-
tion (Figure 6). In contrast, expression of CAMK2GThr287Ala/Arg292Pro
was comparably disruptive asCAMK2GArg292Pro onneuronalmorphol-
ogy and migration (Figure 6). These results indicate that functional
consequences of the CAMK2GArg292Pro mutation are independent of
Thr287 phosphorylation.
We next examined whether the p.Arg292Pro mutation gain-of-
function requires the catalytic function of the kinase by introduc-
ing a p.Lys43Arg mutation, known to severely disable CAMK2G
catalytic function. Compared to the severe neurodevelopmen-
tal impairments resulting from expression of CAMK2GArg292Pro,
CAMK2GArg292Pro/Lys43Arg had a significantly milder impact on total
neurite length and fully rescued arborization (Figure 7A). Moreover,
CAMK2GArg292Pro/Lys43Arg expressing cells targeted at E14.5 by in
utero electroporation revealed no discernible migration deficits com-
pared to CAMK2GWT (Figure 2F, Figure 7C and D), indicating that the
pathogenicity of CAMK2GArg292Pro requires its kinase activity.
Since the introduction of the p.Lys43Arg mutation into the exclu-
sively cytosolic CAMK2GArg292Pro isoform strongly attenuates the
pathogenicity of the Arg292Pro mutation, we hypothesized that
the pathogenicity of the p.Arg292Pro mutation is independent of
its function as a nuclear Ca/CaM shuttle. To investigate this, we
introduced the p.Lys43Arg mutation into the CAMK2G that carries
an NLS, resulting in CAMK2G-NLSArg292Pro. Analysis of the CAMK2G-
NLSLys43Arg/Arg292Pro double mutation showed that the Lys43Arg
mutation did not alter the nuclear targeting deficit (Suppl. Fig. S6A
and B). Nevertheless, both neuronal maturation and migration were
again fully rescued by introducing the p.Lys43Arg mutation (Suppl.
Fig. S6C–E).
Taken together these experiments suggest that the p.Arg292Pro
mutation renders CAMK2G constitutively active and impairs neu-
ronal maturation andmigration independent of its role as a Ca2+/CaM
shuttle.
3.1.6 The CAMK2GArg292Pro analogousmutations in
CAMK2A and CAMK2B exhibit similar neurodevelopmental
pathogenicity as CAMK2GArg292Pro
Given that CAMK2GArg292Pro exerts the pathogenic phenotype we
describe via a non-nuclear function, we hypothesized that the anal-
ogous mutations in CAMK2A or CAMK2B lacking an NLS might
be similarly disruptive for neurodevelopment, given that they are
almost exclusively localized to the cytoplasm. Therefore, we gener-
ated the analogous mutations of CAMK2GArg292Pro in CAMK2A and
CAMK2B (Figure 8A). We first investigated the basal Thr286 and
Thr287 phosphorylation levels of CAMK2A and CAMK2B, respec-
tively. Whereas basal auto-phosphorylation in HEK-293T cells of
CAMK2GWT was clearly evident, that of CAMK2AWT or CAMK2BWT
was hardly detectible (Figure 8B). In contrast, both CAMK2ALys291Pro
and CAMK2BLys292Pro exhibited robust basal Thr286/287 phospho-
rylation (Figure 8C), indicating that this Arg/Lys residue functions
critically across multiple CAMK2 isoforms for constraining phospho-
transferase activity.
We next tested whether the expression of CAMK2ALys291Pro and
CAMK2BLys292Pro impacts the morphological development of cul-
tured primary hippocampal neurons (Figure 8D). No changes in neu-
ronal morphologywere observedwith expression of CAMK2AWT (Fig-
ure 8E). Expression of CAMK2BWT did result in a small but significant
decrease in arborization, but without changes in total neurite length
(Figure 8E). In contrast, expression of either CAMK2ALys291Pro or
CAMK2BLys292Pro each resulted in substantial alterations of neuronal
morphology (Figure 8D and E).
Lastly, we evaluated the impact of CAMK2ALys291Pro and
CAMK2BLys292Pro on in vivo neural cell migration. The majority of
cells expressing either CAMK2AWT or CAMK2BWT migrated normally
to layer 2/3 of the somatosensory cortex (Figure 8F). However, expres-
sion of either CAMK2ALys291Pro or CAMK2BLys292Pro caused a severe
disruption of migration, analogous to the effect of CAMK2GArg292Pro
(Figure 8F).
Therefore, our findings suggest a strong functional conserva-
tion across the major brain-expressed CAMK2 isoforms of the ID-
associated CAMK2G p.Arg292Pro mutation for which neurodevel-
opmental pathogenicity is mediated by a gain-of-function through
enhanced cytoplasmic phosphotransferase activity.
4 DISCUSSION
In the present study, we describe two unrelated patients with severe
ID, carrying a de novo CAMK2G p.Arg292Pro mutation and made use
of an in vitromorphology and in vivomigration assay to investigate the
pathogenicity of this mutation.
Mutations in CAMK2A and CAMK2B have recently been shown to
cause ID, severely delayed speech and behavioral issues (Küry et al.,
2017). Apart from these common features, there is much variability
between the different CAMK2 patients. The two patients described
here carrying a mutation in CAMK2G share similar features with
CAMK2A/CAMK2B-mutated patients (e.g., ID and hypotonia), but also
show clear differences such as facial dysmorphisms. The continuous
identification of individuals with ID carrying mutations in the CAMK2
genes, may enable further characterization of specific characteristics
for the CAMK2-dependent syndrome.
We have established several lines of mechanistic evidence indi-
cating that the p.Arg292Pro mutation acts as a gain-of-function,
with regard to catalytic activity of the kinase, but as a loss-of-
function with regard to its nuclear localization. First, we showed
that expression of CAMK2G mutants that reduce kinase activity
by interfering with Ca2+/CaM binding or rendering the protein
kinase-dead, do not recapitulate the neurodevelopmental phe-
notypes exhibited by expression of CAMK2GArg292Pro. Second,
we showed that the CAMK2G p.Arg292Pro mutation causes
increased phosphotransferase activity as well as increased CaM
affinity, resulting in increased Thr287 phosphorylation. Third,
we showed that expression of the constitutively active mutant
CAMK2GThr287Asp/Thr306Val/Thr307Ala phenocopies the neurodevel-
opmental impairments seen with expression of CAMK2GArg292Pro.
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F IGURE 7 Silencing the catalytic activity of CAMK2GArg292Pro normalizes neuronal maturation andmigration. (A) Representative confocal
images of hippocampal neurons transfected onDIV7with control vector or CAMK2GLys43Arg/Arg292Pro (K43R/R292P). Transfected neurons are
identified by the tdTOMATO (red). (B) Summary bar graphs of total neurite length and arborizationmeasured for each condition and normalized
to the control vector (total neurite length: one-way ANOVA, F[2,61]= 18.50, P= 5.25E-07; CAMK2GLys43Arg/Arg292Pro vs. control vector: P= 0.05;
CAMK2GArg292Pro: P= 0.01; arborization: one-way ANOVA, F[2,61]= 15.02, P= 4.97E-06; CAMK2GLys43Arg/Arg292Pro vs. control vector, P= 0.16;
CAMK2GArg292Pro, P= 0.01). (C) Representative image of a P20 pup in utero electroporated at E14.5 with CAMK2GLys43Arg/Arg292Pro. tdTOMATO
positive cells represent neurons successfully targeted. DAPI (blue) counterstaining is used to identify general cortical structure. (D) Left:
quantification of the neuronal migration pattern from the Layer 1 (L1) to the intermediate zone (IZ); Right: analysis of the percentage of targeted
cells that reach the outer layers of the cortexmeasured as the sum of bin 1–4 (CAMK2GWT vs. CAMK2GLys43Arg/Arg292Pro, t[15]= 0.83, P= 0.42,
two-tailed unpaired t-test).The dotted line indicates the CAMK2GWT level, see Figure 2F for comparison. Arrowheads indicate layer 2/3 of the
somatosensory cortex, whereas the arrow indicates the subventricular zone (SVZ). Data in (B) and (D) are presented asmean±SEM.Numbers (X/Y)
depicted in the bar graphs represent the total number of cells (X) and number of independent cultures (Y) (B) or number of pictures (D) analyzed
Finally, we showed that CAMK2G-NLSArg292Pro is deficient in nuclear
localization. Taken together, we propose a model whereby the
p.Arg292Pro mutation renders CAMK2G constitutively active albeit
with a reduced protein half-life, either due to intrinsic instability or
targeted degradation. Notably, expression of the constitutively active
CAMK2GThr287Asp/Thr306Val/Thr307Ala mutant in HEK-293T cells also
resulted in lower CAMK2G protein expression but the higher activity
of the expressed protein led to the gain-of-function phenotype.
Additionally, mice expressing the CAMK2AThr305Val/Thr306Ala protein,
which lacks auto-inhibitory function, exhibits a two-fold reduction
in CAMK2A protein but similarly produces a net gain-of-function
phenotype (Elgersma et al., 2002). Since CAMK2 is highly dependent
on a Ca2+ stimulus for activity, even low expression of a constitutively
active form such as CAMK2GArg292Pro may elicit gain-of-function
effects. Future studies using a targeted mouse mutant and genome-
edited human pluripotent stem cells would provide further insights
regarding the endogenous regulation of CAMK2GArg292Pro protein
levels.
Although the effect of the CAMK2GArg292Pro mutation has not pre-
viously been studied, our finding that its pathogenicity derives from
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F IGURE 8 CAMK2ALys291Pro and CAMK2BLys292Pro exhibit similar neurodevelopmental pathogenicity as CAMK2GArg292Pro. (A) Alignment of
the protein sequence of CAMK2A, CAMK2B, and CAMK2G showing that the Arginine (R) at 292 in CAMK2G is a Lysine (K) in CAMK2A and
CAMK2B. (B) Representative western blot of HEK-293T cells transfected with control vector, CAMK2AWT, CAMK2ALys291Pro (K291P),
CAMK2BWT, or CAMK2BLys292Pro (K292P). (C) Quantification of the levels of CAMK2–Thr286/Thr287 phosphorylation, normalized against total
CAMK2 in the different conditions (CAMK2AWT vs. CAMK2ALys291Pro, t[12]= 2.7, P= 0.01; CAMK2BWT vs. CAMK2BLys292Pro, t(8)= 2.18,
P= 0.03, one-tailed unpaired t-test). (D) Representative confocal images of hippocampal neurons transfected onDIV7with control vector,
CAMK2AWT, CAMK2ALys291Pro, CAMK2BWT, or CAMK2BLys292Pro. Transfected neurons are identified by the tdTOMATO (red). (E) Summary bar
graphs of total neurite length and arborizationmeasured for each condition and normalized to the control vector (CAMK2A total neurite length:
one-way ANOVA, F[2,56]= 3.38, P= 0.04; control vector vs. CAMK2AWT, P= 0.9; CAMK2ALys291Pro, P= 0.1, CAMK2AWT vs. CAMK2ALys291Pro,
P= 0.06; CAMK2A arborization: one-way ANOVA F[2,56]= 6.37, P= 0.003; control vector vs. CAMK2AWT, P= 0.6; CAMK2ALys291Pro, P= 0.04,
CAMK2AWT vs. CAMK2ALys291Pro, P= 0.003; CAMK2B total neurite length: one-way ANOVA, F[2,55]= 27.26, P= 5,9E-09; control vector vs.
CAMK2BWT, P= 0.5; CAMK2BLys292Pro, P= 0.0001, CAMK2BWT vs. CAMK2BLys292Pro, P= 0.0001; CAMK2B arborization: one-way ANOVA
F[2,55]= 29.07, P= 2.4E-09; control vector vs. CAMK2BWT, P= 0.02; CAMK2BLys292Pro, P= 0.0001, CAMK2BWT vs. CAMK2BLys292Pro,
P= 0.0001). (F) Representative images of P20–P22 pups in utero electroporated at E14.5 with control vector, CAMK2AWT, CAMK2ALys291Pro,
CAMK2BWT, or CAMK2BLys292Pro. tdTOMATO positive cells represent neurons successfully targeted. Arrowheads indicate layer 2/3 of the
somatosensory cortex, whereas the arrowhead indicates the subventricular zone (SVZ). Right: quantification of the neuronal migration pattern
from the Layer 1 (L1) to the intermediate zone (IZ); insets represent the percentage of targeted cells that reach the outer layers of the cortex
measured as the sum of bin 1–4 (CAMK2AWT vs. CAMK2ALys291Pro, t(29)= 12.97, P= 1.34E-13, unpaired two-tailed t-test; CAMK2BWT vs.
CAMK2BLys292Pro, t(23)= 13.33, P= 2.64E-12, unpaired two-tailed t-test). Data in (C) and (E) are presented asmean± SEM. Numbers (X/Y)
depicted in the bar graphs represent the number of samples (C) or the total number of cells (X) and number of independent cultures (Y) (E) analyzed
a gain-of-function is consistent with the rich knowledge of CAMK2
biochemistry (for reviews see, Hudmon and Schulman (2002); Lisman
et al. (2002)). In the basal state, the auto-regulatory domain functions
to suppress catalytic activity by maintaining the kinase in an inactive
conformation and blocking access of external substrates to the
binding pocket. Binding of Ca2+/CaM to the auto-regulatory domain
displaces it to allow the active conformation and opening the substrate
binding pocket. In the process, it exposes Thr286 (CAMK2A)/Thr287
PROIETTI ONORI ET AL. 15
(CAMK2B and CAMK2G) for auto-phosphorylation, which disables
the inhibitory function of the auto-regulatory domain and results in
Ca2+/CaM independent (autonomous) activity. The auto-regulatory
domain consists of several residues that participate in auto-inhibition,
one of which is located at amino acid position 291 in CAMK2A (Smith,
Colbran, Brickey, & Soderling, 1992). Indeed, for CAMK2A it has
previously been shown that mutation of Lysine 291 (equivalent to
Arginine 292 in CAMK2G) to Alanine increases the Ki for inhibitory
peptides and reduced the inhibitory potency of the auto-regulatory
domain (Smith et al., 1992). Notably, mutation of CAMK2A just three
residues downstream, fromAsparagine 294 to aspartic acid, generates
an even greater enhancement of constitutive activity than the phos-
phomimetic p.Thr286Asp mutation. Therefore, it is possible that the
disruptive nature of the Proline substitution in p.Arg292Pro reduces
the contribution of the critical Asparagine for auto-inhibition resulting
in enhanced constitutive activity (Yang & Schulman, 1999). Addi-
tionally, mutation of CAMK2A Lysine 291 to Glutamic acid reduced
the relative KCaM by 50%, thereby increasing CaM binding (Yang &
Schulman, 1999). Hence, these structural and biochemical findings are
entirely consistent with our finding that the p.Arg292Pro mutation
would generates a constitutively active kinase that facilitates CaM
binding and promotes Thr287 phosphorylation that delinks kinase
activity from complete dependence on Ca2+ stimulus for activity.
Our finding that knockdownofCAMK2Gaffects neuronal arboriza-
tion, which could be rescued by CAMK2G expression with or with-
out an NLS, but not by heterologous CAMK2A or CAMK2B overex-
pression indicates that cytosolic CAMK2G plays a unique role in neu-
ronal development, and that loss-of-function mutations or haploinsuf-
ficiency could potentially be disruptive. Indeed, according to ExAC, the
probability of CAMK2G being LoF intolerant is high (pLI= 0.99). How-
ever, to our knowledge no patient with a neurodevelopmental disor-
der has yet been found carrying an indel or a nonsense mutation in
the CAMK2G gene. Interestingly, another CAMK2G candidate variant
(CAMK2G c.1075G > A p.Val359Met) was found in a patient with a
developmental disorder in the Deciphering Developmental Disorders
Study (DecipheringDevelopmentalDisorders Study, 2017). In contrast
to the p.Arg292Pro mutation, this variant is located in the association
domain of the protein, which makes it difficult to predict a priori if and
how it affects CAMK2G protein function.
Very few studies have looked at the function of CAMK2G in neu-
rons. Only recently, a first hint for CAMK2G having a unique function
in spinal cord ganglion cells was published (Ma et al., 2014). This study
indicated that CAMK2G functions as a shuttle to transport Ca2+/CaM
from the cell surface and cytoplasm to the nucleus, a function that
does not require its catalytic activity but depends on phosphorylation
of its Thr287 by a second CAMK2 holoenzyme, and on the integrity of
its NLS to initiate changes in gene expression in response to specific
Ca2+ signals. Our study further expands the mechanistic evidence
underlying the function of CAMK2G in neurons by demonstrating
that reduced levels of CAMK2G resulted in a significant elaboration
of neuronal morphology. Notably, this effect could be reversed by
expression of CAMK2Gwith or without an NLS, but not by expression
of CAMK2A or CAMK2B. Therefore, we conclude that cytosolic
CAMK2G functions to constrain dendritic arborization. In contrast,
whereas CAMK2A knockdown does not affect dendritic arborization,
CAMK2Bknockdownhas been shown to reduce dendritic arborization
of primary hippocampal neurons (Fink et al., 2003), together suggest-
ing distinct neurodevelopmental functions of the various CAMK2
isoforms.
Even though a subset of CAMK2G isoforms contains an NLS
(Takeuchi, Fukunaga, & Miyamoto, 2002), we did not observe differ-
ential effects on neuronal morphology or neural cell migration that
were dependent on the presence of the NLS domain. However, we
did find that CAMK2G-NLSArg292Pro is localized predominantly to the
cytosol, whereas CAMK2G-NLSWT is located in both the nucleus and
cytosol, indicating that the p.Arg292Pro mutation interferes with its
nuclear localization. However, given that abrogation of the phospho-
transferase activity (via the Lys43Arg mutation) fully rescued the
pathogenic effect of the p.Arg292Pro mutation, independently of
the presence or absence of the NLS domain, we conclude that the
pathogenicity of the p.Arg292Pro mutation is most likely unrelated to
its nuclear function.
Our results also demonstrate that the combination of in vitro and in
vivo neurodevelopmental assays provide a robust platform for inves-
tigating the functional pathogenicity of candidate CAMK2 mutations
for ID. Furthermore, by exploiting the wealth of previous data that
has been gathered for the CAMK2 protein (Colbran, 1992; Colbran
& Brown, 2004; Hanson, Meyer, Stryer, & Schulman, 1994; Hudmon
& Schulman, 2002; Rellos et al., 2010; Yang & Schulman, 1999), we
were subsequently able to carefully dissect the biochemical mecha-
nism underlying the pathogenicity of themutation.
In conclusion, we show that CAMK2G is indispensable for nor-
mally developing neurons. Moreover, we have demonstrated that the
pathogenicity of the de novo CAMK2G p.Arg292Pro mutation is medi-
ated by a gain-of-function through enhanced constitutive enzymatic
activity.
ACKNOWLEDGMENTS
We thank Erika Goedknegt, Minetta Elgersma, Mehrnoush Agha-
davoud Jolfaei, ChristianG. Bouwkamp, Charlotte de Konink, and Ran-
dall de Joode for technical support.
CONFLICT OF INTEREST STATEMENT
The Greenwood Genetic Center receives fee income from clinical lab-
oratory testing.
ORCID
Martina Proietti Onori http://orcid.org/0000-0003-0360-2894
Sébastien Küry http://orcid.org/0000-0001-5497-0465
Ype Elgersma http://orcid.org/0000-0002-3758-1297
GeeskeM. vanWoerden http://orcid.org/0000-0003-2492-9239
REFERENCES
Bayer, K. U., Löhler, J., Schulman, H., & Harbers, K. (1999). Developmen-
tal expression of the CaM kinase II isoforms: Ubiquitous gamma- and
delta-CaM kinase II are the early isoforms and most abundant in the
16 PROIETTI ONORI ET AL.
developing nervous system. Brain Research. Molecular Brain Research,
70(1), 147–154.
Borgesius, N. Z., van Woerden, G. M., Buitendijk, G. H. S., Keijzer, N.,
Jaarsma, D., Hoogenraad, C. C., & Elgersma, Y. (2011). 𝛽CaMKII plays
a nonenzymatic role in hippocampal synaptic plasticity and learning
by targeting 𝛼CaMKII to synapses. The Journal of Neuroscience: The
Official Journal of the Society for Neuroscience, 31(28), 10141–10148.
https://doi.org/10.1523/JNEUROSCI.5105-10.2011
Colbran, R. J. (1992). Regulation and role of brain calcium/calmodulin-
dependent protein kinase II. Neurochemistry International, 21(4), 469–
497.
Colbran, R. J., & Brown, A. M. (2004). Calcium/calmodulin-dependent pro-
tein kinase II and synaptic plasticity. Current Opinion in Neurobiology,
14(3), 318–327. https://doi.org/10.1016/j.conb.2004.05.008
de Ligt, J.,Willemsen,M.H., vanBon, B.W.M., Kleefstra, T., Yntema,H.G.,…
Kroes, T. (2012). Diagnostic exome sequencing in persons with severe
intellectual disability. The New England Journal of Medicine, 367(20),
1921–1929. https://doi.org/10.1056/NEJMoa1206524
de Quervain, D. J.-F., & Papassotiropoulos, A. (2006). Identification
of a genetic cluster influencing memory performance and hip-
pocampal activity in humans. Proceedings of the National Academy
of Sciences of the United States of America, 103(11), 4270–4274.
https://doi.org/10.1073/pnas.0510212103
DecipheringDevelopmentalDisorders Study. (2017). Prevalence and archi-
tecture of de novo mutations in developmental disorders. Nature,
542(7642), 433–438. https://doi.org/10.1038/nature21062
Elgersma, Y., Fedorov, N. B., Ikonen, S., Choi, E. S., Elgersma, M., Carvalho,
O. M., … Silva, A. J. (2002). Inhibitory autophosphorylation of CaMKII
controls PSD association, plasticity, and learning. Neuron, 36(3), 493–
505.
Fink, C. C., Bayer, K.-U., Myers, J. W., Ferrell, J. E., Schulman, H., & Meyer, T.
(2003). Selective regulation of neurite extension and synapse formation
by the beta but not the alpha isoform of CaMKII. Neuron, 39(2), 283–
297.
Fong, Y. L., Taylor,W. L., Means, A. R., & Soderling, T. R. (1989). Studies of the
regulatory mechanism of Ca2+/calmodulin-dependent protein kinase II.
Mutation of threonine 286 to alanine and aspartate. The Journal of Bio-
logical Chemistry, 264(28), 16759–16763.
Giese, K. P., Fedorov, N. B., Filipkowski, R. K., & Silva, A. J. (1998). Autophos-
phorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP
and learning. Science, 279(5352), 870–873.
Goslin, K., & Banker, G. (1991). Culturing nerve cells. MIT Press: Cambridge,
pp. 251–281.
Hanson, P. I., Kapiloff, M. S., Lou, L. L., Rosenfeld, M. G., & Schulman,
H. (1989). Expression of a multifunctional Ca2+/calmodulin-dependent
protein kinase and mutational analysis of its autoregulation. Neuron,
3(1), 59–70.
Hanson, P. I., Meyer, T., Stryer, L., & Schulman, H. (1994). Dual role of
calmodulin in autophosphorylation of multifunctional CaM kinase may
underlie decoding of calcium signals.Neuron, 12(5), 943–956.
Heist, E. K., Srinivasan, M., & Schulman, H. (1998). Phosphorylation at
the nuclear localization signal of Ca2+/calmodulin-dependent protein
kinase II blocks its nuclear targeting. The Journal of Biological Chemistry,
273(31), 19763–19771.
Hell, J. W. (2014). CaMKII: Claiming center stage in postsynaptic func-
tion and organization. Neuron, 81(2), 249–265. https://doi.org/
10.1016/j.neuron.2013.12.024
Hudmon, A., & Schulman, H. (2002). Neuronal Ca2+/calmodulin-
dependent protein kinase II: The role of structure and autoregula-
tion in cellular function. Annual Review of Biochemistry, 71, 473–510.
https://doi.org/10.1146/annurev.biochem.71.110601.135410
Küry, S., van Woerden, G. M., Besnard, T., Proietti Onori, M., Laty-
pova, X., … Towne, M. C. (2017). De novo mutations in protein
kinase genes CAMK2A and CAMK2B cause intellectual dis-
ability. American Journal of Human Genetics, 101(5), 768–788.
https://doi.org/10.1016/j.ajhg.2017.10.003
Li, K., Zhou, T., Liao, L., Yang, Z.,Wong,C.,Henn, F.,…Hu,H. (2013). 𝛽CaMKII
in lateral habenula mediates core symptoms of depression. Science,
341(6149), 1016–1020. https://doi.org/10.1126/science.1240729
Lisman, J., Schulman, H., & Cline, H. (2002). The molecular basis of CaMKII
function in synaptic and behavioural memory. Nature Reviews. Neuro-
science, 3(3), 175–190. https://doi.org/10.1038/nrn753
Lisman, J., Yasuda, R., & Raghavachari, S. (2012). Mechanisms of CaMKII
action in long-term potentiation. Nature Reviews. Neuroscience.,
https://doi.org/10.1038/nrn3192
Ma, H., Groth, R. D., Cohen, S. M., Emery, J. F., Li, B., Hoedt, E., … Tsien,
R.W. (2014). 𝛾CaMKII shuttles Ca2+/CaM to the nucleus to trigger
CREB phosphorylation and gene expression. Cell, 159(2), 281–294.
https://doi.org/10.1016/j.cell.2014.09.019
Mayford, M., Wang, J., Kandel, E. R., & O'Dell, T. J. (1995). CaMKII regulates
the frequency-response function of hippocampal synapses for the pro-
duction of both LTD and LTP. Cell, 81(6), 891–904.
Ohsako, S., Nakazawa, H., Sekihara, S., Ikai, A., & Yamauchi, T. (1991). Role of
threonine-286 as autophosphorylation site for appearance of Ca2(+)-
independent activity of calmodulin-dependent protein kinase II alpha
subunit. Journal of Biochemistry, 109(1), 137–143.
Pan, Z., Zhu, L.-J., Li, Y.-Q., Hao, L.-Y., Yin, C., Yang, J.-X.,… Cao J. L. (2014).
Epigenetic modification of spinal miR-219 expression regulates chronic
inflammation pain by targeting CaMKII𝛾 . The Journal of Neuroscience:
The Official Journal of the Society for Neuroscience, 34(29), 9476–9483.
https://doi.org/10.1523/JNEUROSCI.5346-13.2014
Payne, M. E., Fong, Y. L., Ono, T., Colbran, R. J., Kemp, B. E., Soderling, T. R.,
&Means, A. R. (1988). Calcium/calmodulin-dependent protein kinase II.
Characterization of distinct calmodulin binding and inhibitory domains.
The Journal of Biological Chemistry, 263(15), 7190–7195.
Pi, H. J., Otmakhov, N., Gaamouch, El, F., Lemelin, D., De Koninck, P., & Lis-
man, J. (2010a). CaMKII control of spine size and synaptic strength:
Role of phosphorylation states and nonenzymatic action. Proceedings of
the National Academy of Sciences of the United States of America, 107(32),
14437–14442. https://doi.org/10.1073/pnas.1009268107
Pi, H. J., Otmakhov, N., Lemelin, D., De Koninck, P., & Lisman, J.
(2010b). Autonomous CaMKII can promote either long-term potenti-
ation or long-term depression, Depending on the state of T305/T306
phosphorylation. The Journal of Neuroscience: The Official Journal
of the Society for Neuroscience, 30(26), 8704–8709. https://doi.org/
10.1523/JNEUROSCI.0133-10.2010
Rellos, P., Pike, A. C. W., Niesen, F. H., Salah, E., Lee, W. H., Delft, von, F.,
& Knapp, S. (2010). Structure of the CaMKIIdelta/calmodulin complex
reveals themolecularmechanismofCaMKII kinaseactivation.PLoSBiol-
ogy, 8(7), e1000426. https://doi.org/10.1371/journal.pbio.1000426
Saito, T. (2006). In vivo electroporation in the embryonic mouse cen-
tral nervous system. Nature Protocols, 1(3), 1552–1558. https://doi.org/
10.1038/nprot.2006.276
Saito, T., & Nakatsuji, N. (2001). Efficient gene transfer into the embry-
onic mouse brain using in vivo electroporation. Developmental Biology,
240(1), 237–246. https://doi.org/10.1006/dbio.2001.0439
Shen, K., & Meyer, T. (1999). Dynamic control of CaMKII translo-
cation and localization in hippocampal neurons by NMDA recep-
tor stimulation. Science, 284(5411), 162–166. https://doi.org/10.1126/
science.284.5411.162
Shioda, N., Sawai, M., Ishizuka, Y., Shirao, T., & Fukunaga, K. (2015).
Nuclear translocation of calcium/calmodulin-dependent protein
PROIETTI ONORI ET AL. 17
kinase II𝛿3 promoted by protein phosphatase-1 enhances brain-
derived neurotrophic factor expression in dopaminergic neurons.
Journal of Biological Chemistry, 290(35), 21663–21675. https://doi.org/
10.1074/jbc.M115.664920
Silva, A. J., Paylor, R., Wehner, J. M., & Tonegawa, S. (1992a). Impaired spa-
tial learning in alpha-calcium-calmodulin kinase II mutant mice. Science,
257(5067), 206–211.
Silva, A. J., Stevens, C. F., Tonegawa, S., & Wang, Y. (1992b). Deficient hip-
pocampal long-term potentiation in alpha-calcium-calmodulin kinase II
mutant mice. Science, 257(5067), 201–206.
Smith,M.K., Colbran,R. J., Brickey,D.A.,&Soderling, T. R. (1992). Functional
determinants in the autoinhibitory domain of calcium/calmodulin-
dependent protein kinase II. Role of His282 andmultiple basic residues.
The Journal of Biological Chemistry, 267(3), 1761–1768.
Tabata, H., & Nakajima, K. (2001). Efficient in utero gene transfer system to
the developingmouse brain using electroporation: Visualization of neu-
ronalmigration in thedeveloping cortex.Neuroscience,103(4), 865–872.
Takeuchi, Y., Fukunaga, K., & Miyamoto, E. (2002). Activation of nuclear
Ca(2+)/calmodulin-dependent protein kinase II and brain-derived neu-
rotrophic factor gene expression by stimulation of dopamine D2 recep-
tor in transfected NG108-15 cells. Journal of Neurochemistry, 82(2),
316–328.
Taniguchi, Y., Young-Pearse, T., Sawa, A., & Kamiya, A. (2012). In utero elec-
troporation as a tool for genetic manipulation in vivo to study psychi-
atric disorders: From genes to circuits and behaviors. The Neuroscientist,
18(2), 169–179. https://doi.org/10.1177/1073858411399925
Tobimatsu, T., & Fujisawa,H. (1989). Tissue-specific expression of four types
of rat calmodulin-dependent protein kinase IImRNAs.The Journal of Bio-
logical Chemistry, 264(30), 17907–17912.
van Woerden, G. M., Hoebeek, F. E., Gao, Z., Nagaraja, R. Y., Hoogenraad,
C. C., Kushner, S. A., … Elgersma, Y. (2009). betaCaMKII controls the
direction of plasticity at parallel fiber-Purkinje cell synapses. Nature
Neuroscience, 12(7), 823–825. https://doi.org/10.1038/nn.2329
Vissers, L. E. L. M., Gilissen, C., & Veltman, J. A. (2016). Genetic studies
in intellectual disability and related disorders. Nature Reviews. Genetics,
17(1), 9–18. https://doi.org/10.1038/nrg3999
Waldmann, R., Hanson, P. I., & Schulman, H. (1990). Multifunctional
Ca2+/calmodulin-dependent protein kinase made Ca2+ independent
for functional studies. Biochemistry, 29(7), 1679–1684.
Waxham, M. N., Aronowski, J., Westgate, S. A., & Kelly, P. T. (1990). Muta-
genesis of Thr-286 in monomeric Ca2+/calmodulin-dependent protein
kinase II eliminates Ca2+/calmodulin-independent activity. Proceedings
of the National Academy of Sciences of the United States of America, 87(4),
1273–1277.
Yang, E., & Schulman, H. (1999). Structural examination of autoregulation
of multifunctional calcium/calmodulin-dependent protein kinase II. The
Journal of Biological Chemistry, 274(37), 26199–26208.
SUPPORTING INFORMATION
Additional supporting informationmay be found online in the Support-
ing Information section at the end of the article.
How to cite this article: Proietti Onori M, Koopal B,
Everman DB, et al. The intellectual disability-associated
CAMK2G p.Arg292Pro mutation acts as a pathogenic gain-
of-function. Human Mutation. 2018;1–17. https://doi.org/
10.1002/humu.23647
